Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market.

How Big Is The Glycomics or Glycobiology Market In 2025?
The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification.

The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analytics, expansion in glycobiology-based drug development, integration of glycomics in disease biomarker discovery, personalized medicine, and glycan-based therapeutics. Major trends in the forecast period include cross-disciplinary collaborations, glycosylation patterns in disease mechanisms, innovative precision medicine and personalized therapies, advancements in glycoanalytical tools, glycans in immunotherapy and vaccines.

Get your free sample today:
https://www.thebusinessresearchcompany.com/sample.aspx?id=8749&type=smp

What Are The Major Factors Driving The Glycomics or Glycobiology Global Market Growth?
The increase in demand for medicines for the treatment of several severe chronic diseases is expected to propel the growth of the glycomics or glycobiology market going forward. Chronic diseases are health problems that are usually long-term and can be controlled but not healed. A glycomics study studies changes in glycosylation and its functions, which helps in the development of drugs and related medications for several severe chronic diseases. For instance, in 2022, according to Cancer Facts and Figures 2022–2024, a scientific paper by the American Cancer Society, there would be 22.5 million cancer (a chronic disease) survivors by 2032, which is projected to reach 26 million by 2040. Thus, the increase in demand for medicines for the treatment of several severe chronic diseases drives the glycomics or glycobiology market.

Glycomics or Glycobiology Market Report Segmentation Analysis
The glycomics or glycobiologymarket covered in this report is segmented –

1) By Product: Enzymes; Kits; Reagents And Chemicals; Instruments; Carbohydrates
2) By Application: Drug Discovery And Development; Disease Diagnostics; Other Applications
3) By End-User: Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Clinical Laboratories

Subsegments:
1) By Enzymes: Glycosidases; Glycosyltransferases; Sialidases
2) By Kits: Glycan Analysis Kits; Glycobiology Research Kits
3) By Reagents And Chemicals: Monosaccharides; Oligosaccharides; Chemical Modifiers
4) By Instruments: Mass Spectrometers; Chromatography Systems; Imaging Systems
5) By Carbohydrates: Natural Carbohydrates; Synthetic Carbohydrates

Emerging Trends And Strategic Opportunities In The Glycomics or Glycobiology Market
Investments in research and development activities are a key trend gaining popularity in the glycomics or glycobiology market. Major research and development institutions are funding research centers for glycobiology, aiming for the research and development of glycomics or glycobiology. For instance, in August 2022, Griffith University, an Australia-based Institute for Glycomics, launched the ACRF International Centre for Cancer Glycomics with a $2.6 million ACRF grant that is dedicated to achieving cancer glycocoding. This is a unique facility, with a better understanding of the glycocode that leads to the translation of novel discoveries and clinical outcomes that would help cancer patients improve their lives.

What Are The Top Players Operating In The Glycomics or Glycobiology Market?
Major companies operating in the glycomics or glycobiology market are Aligent Technologies Inc., Bruker Corporation, Merck Co. & KgaA, New England Biolabs Inc., Danaher Corporation, Shimadzu Corporation, ProZyme Inc., Takara Bio Inc., Asparia Glycomics SL, Lectenz Bio, Chemily Glycoscience LLC, Z Biotech LLC, RayBiotech Inc., Thermo Fisher Scientific Inc., Promega Corporation, Bio-Techne Corp., AMS Bio LLC, Ludger Ltd., CD BioGlyco Ltd., GlycoDiag SAS, Kode Biotech Limited, Glyxera GmBH, Glycomix Ltd., R&D Systems Inc.

View the full glycomics or glycobiology market report here:
https://www.thebusinessresearchcompany.com/report/glycomics-or-glycobiology-global-market-report

Which Region Holds The Largest Market Share In The Glycomics or Glycobiology Market?
North America was the largest region in the glycomics or glycobiology market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomics or glycobiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company